DC Brater - Clinical Pharmacology & Therapeutics, 2009 - nature.com Jump to main content; Jump to navigation; nature.com homepage; Publications AZ
index; Browse by subject; ASCPT. My account; Submit manuscript; ... Cited by 2 - Related articles - All 3 versions
LA Stevens, AS Levey - Clinical pharmacology and therapeutics, 2009 - ncbi.nlm.nih.gov 1: Clin Pharmacol Ther. 2009 Nov;86(5):465-7. Use of the MDRD study equation to
estimate kidney function for drug dosing. Stevens LA, Levey AS. ... Cited by 3 - Related articles - All 2 versions
SM Huang, R Temple, S Xiao, L Zhang, LJ … - Clinical Pharmacology & Therapeutics, 2009 - nature.com To optimize drug therapy for individuals, it is critical to understand how
various intrinsic (eg, age, gender, race, genetics, organ impairment) and
extrinsic factors (eg, diet, smoking, concomitantly administered drugs) ... Cited by 1 - Related articles
RL Lalonde, JA Wagner - Clinical Pharmacology & Therapeutics, 2009 - nature.com Jump to main content; Jump to navigation; nature.com homepage; Publications AZ
index; Browse by subject; ASCPT. My account; Submit manuscript; ... Cited by 1 - Related articles - All 3 versions
AA Soares, TF Eyff, RB Campani, L Ritter, JL … - Clinical Chemistry and Laboratory Medicine, 2009 - reference-global.com Chronic kidney disease (CKD) is defined as the pres- ence of kidney damage or a
glomerular filtration rate (GFR) -60 mL/min/1.73 m2 for three or more months.
Measurement of serum creatinine is the most com- monly used method to ... Cited by 1 - Related articles - All 4 versions
LA Stevens, CH Schmid, YL Zhang, J Coresh, … - Nephrology Dialysis Transplantation, 2009 - ERA-EDTA Results. The mean mGFR was 68, 67 and 68 ml/min/ 1.73 m 2 in the development,
internal validation and external validation datasets, respectively. In external
validation, an equation that included a linear age term and spline terms in ... Related articles - All 3 versions
DE Weiner, M Krassilnikova, H Tighiouart, … - BMC nephrology, 2009 - pubmedcentral.nih.gov Participants in the Atherosclerosis Risk in Communities Study and the
Cardiovascular Health Study were classified into 4 groups based on two eGFR
assessments separated by 35.3 ± 2.5 months: sustained eGFR < 60 mL/min per ... Related articles - All 6 versions
ED Poggio, WE Braun, C Davis - Clinical Journal of the American Society of Nephrology, 2009 - Am Soc Nephrol Living kidney donor transplantation is now a common treatment for ESRD because
it provides excellent outcomes to transplant recipients and is considered a safe
procedure for prospective donors. The short- and long-term safety of ... Related articles - All 3 versions
N Syndrome - canadiancpd.medscape.com Epidemiologic evidence on the VTE risk in the ESRD population is very limited.
Initial postmortem examinations suggested that VTE is a rare event in ESRD.
[8-11] However, the series by Wiesholzer et al. [11] in 1999 was the first ...
AI Med - Ann Intern Med, 2009 - Am Coll Physicians Dr. Wong reports that mean estimated GFR computed using the CKD-EPI equation is
higher than using the MDRD Study equation in a young Asian population
(presumably with high GFR) of mixed ethnicity. This result confirms our ...
